These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9816472)

  • 1. Nitric oxide availability in diabetes mellitus.
    Honing ML; Morrison PJ; Banga JD; Stroes ES; Rabelink TJ
    Diabetes Metab Rev; 1998 Sep; 14(3):241-9. PubMed ID: 9816472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
    Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
    Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
    Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
    Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of tetrahydrobiopterin in the function of nitric oxide synthase, and its cytoprotective effect (Review).
    Shimizu S; Ishii M; Momose K; Yamamoto T
    Int J Mol Med; 1998 Nov; 2(5):533-40. PubMed ID: 9858648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase.
    Soro-Paavonen A; Zhang WZ; Venardos K; Coughlan MT; Harris E; Tong DC; Brasacchio D; Paavonen K; Chin-Dusting J; Cooper ME; Kaye D; Thomas MC; Forbes JM
    J Hypertens; 2010 Apr; 28(4):780-8. PubMed ID: 20186099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability.
    Münzel T; Li H; Mollnau H; Hink U; Matheis E; Hartmann M; Oelze M; Skatchkov M; Warnholtz A; Duncker L; Meinertz T; Förstermann U
    Circ Res; 2000 Jan; 86(1):E7-E12. PubMed ID: 10625313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide and vascular insulin resistance.
    Wu G; Meininger CJ
    Biofactors; 2009; 35(1):21-7. PubMed ID: 19319842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency.
    Vaziri ND; Ni Z; Oveisi F; Liang K; Pandian R
    Hypertension; 2002 Jan; 39(1):135-41. PubMed ID: 11799092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of nitric oxide-mediated blood flow regulation in diabetes mellitus.
    Toda N; Imamura T; Okamura T
    Pharmacol Ther; 2010 Sep; 127(3):189-209. PubMed ID: 20546780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial dysfunction in normal and abnormal glucose metabolism.
    Esper RJ; Vilariño JO; Machado RA; Paragano A
    Adv Cardiol; 2008; 45():17-43. PubMed ID: 18230954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide, a janus-faced therapeutic target for diabetic microangiopathy-Friend or foe?
    Yamagishi S; Matsui T
    Pharmacol Res; 2011 Sep; 64(3):187-94. PubMed ID: 21635951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide, oxidative excess, and vascular complications of diabetes mellitus.
    Endemann DH; Schiffrin EL
    Curr Hypertens Rep; 2004 Apr; 6(2):85-9. PubMed ID: 15010009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial nitric oxide in diabetes mellitus: too much or not enough?
    Farkas K; Sármán B; Jermendy G; Somogyi A
    Diabetes Nutr Metab; 2000 Oct; 13(5):287-97. PubMed ID: 11105972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Endothelial function].
    Higashi Y; Yoshizumi M
    Nihon Rinsho; 2003 Jul; 61(7):1138-44. PubMed ID: 12877075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postprandial insulin resistance in Zucker diabetic fatty rats is associated with parasympathetic-nitric oxide axis deficiencies.
    Afonso RA; Fernandes AB; Santos C; Ligeiro D; Ribeiro RT; Lima IS; Patarrao RS; Videira PA; Caldeira J; Macedo MP
    J Neuroendocrinol; 2012 Oct; 24(10):1346-55. PubMed ID: 22672343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymmetric dimethylarginine (ADMA) and other endogenous nitric oxide synthase (NOS) inhibitors as an important cause of vascular insulin resistance.
    Toutouzas K; Riga M; Stefanadi E; Stefanadis C
    Horm Metab Res; 2008 Sep; 40(9):655-9. PubMed ID: 18792879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial Dysfunction in Human Diabetes Is Mediated by Wnt5a-JNK Signaling.
    Bretón-Romero R; Feng B; Holbrook M; Farb MG; Fetterman JL; Linder EA; Berk BD; Masaki N; Weisbrod RM; Inagaki E; Gokce N; Fuster JJ; Walsh K; Hamburg NM
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):561-9. PubMed ID: 26800561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress in diabetes-induced endothelial dysfunction involvement of nitric oxide and protein kinase C.
    Pricci F; Leto G; Amadio L; Iacobini C; Cordone S; Catalano S; Zicari A; Sorcini M; Di Mario U; Pugliese G
    Free Radic Biol Med; 2003 Sep; 35(6):683-94. PubMed ID: 12957660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-acetylcysteine protects against diabetic nephropathy through control of oxidative and nitrosative stress by recovery of nitric oxide in rats.
    Nogueira GB; Punaro GR; Oliveira CS; Maciel FR; Fernandes TO; Lima DY; Rodrigues AM; Mouro MG; Araujo SRR; Higa EMS
    Nitric Oxide; 2018 Aug; 78():22-31. PubMed ID: 29778909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes, oxidative stress, nitric oxide and mitochondria function.
    Friederich M; Hansell P; Palm F
    Curr Diabetes Rev; 2009 May; 5(2):120-44. PubMed ID: 19442097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.